Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

J Charles Dockendorff


  • Director at Haemonetics Corp (HAE), 2017-07-31
  • Director at Keysight Technologies Inc. (KEYS), 2017-06-13
  • Director at Hologic Inc (HOLX), 2017-05-16
  • Director at Boston Scientific Corp (BSX), 2017-05-11
  • Evp & Chief Financial Officer at Covidien Plc (COV), 2015-01-28
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
KEYS $37.81 13,210 Director 51,800 2017-06-09 Filing
BSX $16.49 30,000 Director 41,598 2016-02-12 Filing
COV $37.24 5,500 Officer 98,339 2010-08-04 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
COV $72.50 90,730 Officer 112,131 2014-03-28 Filing
COV $69.50 90,000 Officer 112,027 2014-01-10 Filing
COV $66.22 39,397 Officer 111,273 2013-11-15 Filing
COV $63.71 391 Officer 137,819 2013-08-08 Filing
COV $63.15 94,797 Officer 138,210 2013-08-07 Filing